Assembly Health Committee advances bills on abortion access, emergency reproductive care, syringe access and housing supports; most measures move to policy or财政

The California State Assembly Health Committee on April 8 advanced a set of bills touching reproductive health, public‑health harm reduction, substance‑use policy and Medi‑Cal benefits, moving the measures to subsequent policy or budget committees for further action.

Committee members voted to move bills including AB 54 (access to medication abortion protections), AB 551 (emergency‑department reproductive care pilot grants), AB 260 (safeguards for medication abortion and telehealth), AB 309 (removing sunset dates on syringe access laws), AB 536 (protecting colorectal cancer screening coverage), AB 804 (require DHCS to seek Medi‑Cal housing support benefit approval), AB 594 (student health insurance protections), AB 836 (midwifery workforce analysis), AB 1037 (updates to substance‑use disorder laws), AB 1418 (health‑care workforce reporting) and AB 1500 (maintenance and expansion of abortion.ca.gov). Many of the bills passed on voice votes or were ordered “do pass” and were referred to appropriations or other committees as recorded at the hearing.

Why it matters: the package bundles near‑term protections for medication abortion and expanded access to reproductive services with longer‑term public‑health measures. Committee testimony threaded two themes: (1) ensuring California preserves and expands access to evidence‑based reproductive care after federal shifts and legal challenges, and (2) aligning public‑health law with harm‑reduction practices and Medi‑Cal service design to reduce preventable illness and health system costs.

Key developments and testimony

AB 54 — Access to Safe Abortion Care Act: Assemblymember Maggie Krell, the bill’s author, and Tiffany Brokaw, deputy attorney general and legislative advocate (for Attorney General Rob Bonta), said AB 54 would shield manufacturers, distributors, pharmacies and authorized providers involved in the medication‑abortion supply chain from civil, criminal and professional discipline, and thereby protect access to mifepristone and misoprostol in California. Tyla Adams, reproductive justice manager at Black Women for Wellness Action Project, testified in support and urged the committee to consider equity impacts in access. Opposition testimony from Sophia Laurie, outreach director at California Family Council, argued the bill would permit mail distribution of abortion medication without in‑person medical evaluation and raised safety concerns citing FDA adverse‑event reports. The committee moved AB 54 to the judiciary committee on a voice vote.

AB 551 — Emergency department reproductive care pilot: Author Assemblymember (presenting)…